TAG:
Becton Dickinson
2023 Ranking of the World’s Top 13 IVD Corporations
By Robert Michel | From the Volume XXXI, No. 10 – July 22, 2024 Issue
BASED ON 2023 DIAGNOSTICS-RELATED REVENUE, four in vitro diagnostics (IVD) manufacturers continued to lead the global IVD market just as they did in 2022. They are: Thermo Fisher Scientific, Inc., Roche Holdings, Abbott Laboratories, and Danaher Corporation. Th…
October 2, 2023, Intelligence: Late-Breaking Lab News
By Scott Wallask | From the Volume XXX, No. 14 – October 2, 2023 Issue
Forming new relationships with non-traditional care providers is one way clinical laboratories can earn additional revenue. With that in mind, here’s another sign of the changing landscape of primary care. Warehou…
IVD Firms Prepare for OTC, Home Test Market Expansion
By Robert Michel | From the Volume XXX, No. 6 – April 17, 2023 Issue
CEO SUMMARY: With public interest in home testing growing, some IVD manufacturers are preparing to serve a fast-expanding market for over-the-counter and at-home tests. IVD firms are banking on the…
March 27, 2023, Intelligence: Late-Breaking Lab News
By Scott Wallask | From the Volume XXX, No. 5 – March 27, 2023 Issue
Clinical laboratory leaders watching at-home care evolve should note the new partnership between Best Buy and Atrium Health in Charlotte, North Carolina. As part of the deal, Best Buy Health, a division of the retailer, will assist patients in setting up the technology pieces of …
Lab Buys More Instruments as Way to Add Test Volume
By Joseph Burns | From the Volume XXVII No. 9 – June 22, 2020 Issue
CEO SUMMARY: Severe shortages of supplies for COVID-19 lab testing caused one lab director in the Midwest to buy additional instruments while also validating five different COVID-19 tests to run on analyzers the lab used before the pandemic hit. While this strategy allowed the lab to …
March 9, 2020 Intelligence: Late-Breaking Lab News
By Robert Michel | From the Volume XXVII No. 4 – March 9, 2020 Issue
Coronavirus, more specifically, the novel coronavirus that causes the COVID-19 disease, currently dominates global news. This is the third novel strain of coronavirus to emerge as a threat to human health in the past two decades. Severe acute respiratory syndrome (SARS) was identifie…
CURRENT ISSUE
Volume XXXI, No. 14 – October 14, 2024
For the second time in the past 16 months, respected health systems have taken steps to collaborate specifically to advance value-based care. Also, several statewide pilot programs—each involving tens of thousands of newborns—are publishing studies that demonstrate how exome, whole genome sequencing, and rapid whole genome sequencing can deliver both improved patient outcomes and a return on investment.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized